There is no specific drug for neoconjunctivitis, and the clinical treatment is mainly symptomatic. Some patients can be treated with chloroquine phosphate, but it is not considered an effective drug. Some patients can turn the virus negative in a period of time after using the drug. The drug is compared with other drugs with disappearance of fever symptoms and less side effects, and a larger scale of clinical observation is being carried out to compare. Plasma therapy uses a certain titer of virus-specific antibodies in the plasma of recovered patients to reduce the virus level in the patient’s body, thus achieving therapeutic expectations. In this case, highly effective virus-neutralizing antibodies have been detected in the plasma of recovered patients with New Coronary Pneumonia, and the experiment has proved that plasma therapy can effectively kill New Coronary Virus, which is relatively safe and effective for critical patients.